Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IVERMECTIN vs JAKAFI: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IVERMECTIN vs JAKAFI: Safety Overview

Metric IVERMECTIN JAKAFI
Total FAERS Reports 3,018 1,749
Deaths Reported 221 152
Death Rate 7.3% 8.7%
Hospitalizations 600 214
Average Patient Age 53.3 yrs 70.6 yrs
% Female Patients 59.7% N/A
FDA Approval Date Apr 13, 2020 N/A
Manufacturer Asclemed USA, Inc. N/A
Route ORAL N/A
Marketing Status Discontinued N/A